Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OSRA: Aggressive Treatment Strategy in Rheumatoid Arthritis
NCT00451971Phase 4Completed
- Sponsor
- Sanofi
- Start
- Mar 2002
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of leflunomide in rheumatoid arthritis (RA), sponsored by Sanofi. Started Mar 2002; status: completed.
02
Drugs
leflunomide
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT00451971.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00451971.